Impairment of urate excretion is an important mechanism for hyperuricemia in patients with heart failure

Impairment of urate excretion is an important mechanism for hyperuricemia in patients with heart failure

60, Journal of Cardiac Failure Vol. 5 No. 3 Suppl. 2 1999 P-29 P-30 EFFECTS OF POSITIVE ENI)'EXP[RATO.RY PRESSURE (PEEP)"ON. THE RIGHT VENTR[OULAR ...

146KB Sizes 0 Downloads 47 Views

60, Journal of Cardiac Failure Vol. 5 No. 3 Suppl. 2 1999

P-29

P-30

EFFECTS OF POSITIVE ENI)'EXP[RATO.RY PRESSURE (PEEP)"ON. THE RIGHT VENTR[OULAR D[ASTQL[C EUNCT[QN IN PATIENTS WITH LEET CARDIAC FAILURE

IMPAIRMENT O.F, URATE EXCRETION IS AN IMPORTANT MECHANISM FOR HYPERURICEMIA IN PATIENTS WITH HEART FAILURE

Hideyo K.uga.~, Hjros.i Harasawa!, TakaakJ. Nakamoto~ [sap "l-aguchi~ y0sfumi Hori.kawaI Noboru Kar~eko~, Hideaki Sakio2 Department: qf Cardiology arg,d:Pneumology~ ; [ntesive Care Unit 2, D.okk~(,oUniversity School.of Medicine

Shuichi Osaki, Tom Kinugawa, Akihil:o Endo, Masahiko Kato, Tatsuo Kato, Kazuhide Ogino, Osamu Igawa, Ichim Hisatome, and Chi0ki Shigcmasa. The 1st Dept. of Internal Medicine, Tottori University, Yonago 683-8504, Japan.

[Purpose],Th~re have been no reports on the effect of ppsitive endexpiratou/pressure (PEEP) on the right ventricular diastolic function in

B a c k g r o u n d Hypcrnricemia is often observed in patients with heart failure (HF), and increased uric acid production due to hypoxia has been considered as a possible mechanism. This study determ,i~aed~ impaired_urate excret~n contributes to the hyperuricemia in patients with HF. M e t h o d s Serum uric acid (Sua: mg/dl) and unnary urate excretion (Uua: tug,day) wore measured, and fractional uric acid excretion (Cua/Ccr: %) was calculated from renal clearance tests for uric acid (Cua: ml/min) and creatinine (Ccr) in 49 patients with HF (NYHA 1: 19, II: 21, III: 9) and 16 controls. R e s u l t s See Table (mean±SEM, *p<0.05 vs. Control, #p<0.05 "¢s NYHA I). Furosemide dose (F:. rag/day), in.creasedas HF worsened. Sua was significantly-increased in class II-II'I HF patients compared tO confrols. Patientswkh HF had decreases in Uua, Cua, and Cua/Cer. When all subjects were examined together-, S,ua was negatively eorretate4with Cua (r=-0.73, p.<0..0O01}, and with CualCcy-(r-.-O.6.Q, P,<0,.0001)... C o n c l u s i o n s Sua levels incre~tsed as, HF worsened, patien,~s with HF had "me,pairment of urate excre6on, but did not exhibit uric acid. overproductiom Close association betwee.n the degree of imp~j,red urate exc[etign and Sua level s u.ggests that decreased urate excretion is resoonsible for fivoeri_iricemia in oatients With-HF. .... F Sii'a . . . . UU~i " C u a Cua/Ccr

pat ~nts Wth eft;o,ardac fa u(e TherefOrethe ri_ghtvent~cul~r dia~ol.ic ft~ncti:90' waz observed b~(. DoppJer e~h0ca(di0grapby d.uring .P,EE.P. ~Subject~s.and~MeLhods~.Thesu.bjects, were 24 p.atients who were being cared"for at th e inteslve care unit and who required respirators. They were:l.0 without cardiopulmonary disease (7 men and 3 women ;. meaD age, 54 +/- 11 years , N group) and 14 with left. cardi.ac failum (7 men and 7 women; mean age, 66 +/- 7 years, CHF group). For the CHF group, E w0ve, A wave. their ratio (E/A) , E wave dace era:Lion ti,me (DcT)., isovolumic (elaxation time (IRT) were determined before PEEP and re!lowing; 3{J mjn.t~tes qf PEEP 5cmH2O , 10cr0H20 ,. IS.er0H20 . Simu taneous y hemo=dynamc. parameters were rT~asuredby,u,sinE'e~e SyYa0~=Gapzca.thpte(.[ResuJts~l ~0tb DgT an,d .IRTfor th e CHF group were shortened n compar so0 w th the N g~'oup(144 +]- 41, vs 204 +/46 ms, p = Q.005~; 59 +,/- li2, ys 88: +/,- t:9 ms, I? --=0.0Q~)3') 2,. For I~/A, before PEEP De I" IRT, right atrial; (RA) and'tota.pu mona~ vascular resistance (TPR) f,or the OfF group no corre at on was fout?.d,amour E/A, IRA, aod TP~:; but negati,v,eco(rela,t,i.o.nwas~f~und between DcT 0,n~dT,pR, {h = 0 81 p, = 0 QQO5)@nd:[RT and T~pB:(g = 0..7~ p.- 0.002),. 3,. . Comp0re~ w.i~h:the da~, be:fore PE.~_p, E/K ~as redut~ed, ;DcT W..as i sigr~ificantly (p - 0 04). sho.tt-e~ed:at pI~EP liSqr0..H20 ; aad; [IRT ~(as prolonged .~Co~elu.s.ion~Thes~tudysuggested th0t PEEP e;
NYHAII" 25_+5 7,.2_+0;5", ~26~36" 4.3_+0.5* 6.8-+0.7* NYHAtlt 40_+8# 7.6_+0.7*- 336-+27* 3.3-+0.5* 6.6-+1.4"

P.32

P-31 Oj~J¢

Control, . . . . 5.-5~:2-600,-+-34 ~ 7.5~0,6- ).0.7-+1.3 NYHAI' 13---3 6.5±0.4 369-+34* 4.1-+0.7" 6.1_+0.9"

NEpHRCPATHY

IN cHRoNIC

cONGESi"IVE

ROLE OF LEUKEMIA INHIBffOR¥ FACTOR (LIP-)IN DIABETIC CARDIOVASCULAR DISORDER

H E A R T FAILURE

Na0fumi Ikeda, Hjdetomo Nakamo~, Hirokazu Okada, Souichi Sugahara, Hiromichi Suzuki D.ep.artmqnt of Nephr0!ggy:, Saitar0a Medical Scho0!, Saitama, Japan The purpo.s.e of this stqdy, was to identify the factors thatcontribute to, the development of diabetic nephropathy in congestive heart failure. We studied: 40 patients comprom zed • with; dja~etic (DM)(20) or non:diabetic N,DM) nephropathy with c onges~,v,e heart fai!ure (CHF), During 24 r0on,t,_hs, every month b.19oc pressure apd~ lev.els, of serum, creatin!ne were cheoked in- both group. Every. 6 rn0nths ejection fraction (EF) was .rne~mtJr,ed Blood; pr~essure was wffH c0ntr,O led in both groups with ACE nh b tore and ca c u m antagon sts. Despite of well controlle d blood Pre~,~ure during: the studY. 2 patients in DM group and 1 patient in N=DM group were died with acute myocardial infarction and 1, patient in DM group and 1 patient in N-DM groplp were died witil acute cereb,al infarction. 6 patients in DM group, and 4 patients in N-DM group were introduced to hemodialysis therapy. Serial. changes in EF were~ simi!ar~ betwee.n two groups througbqut the study, The rate of progression of renal dysfunct!on was faster in DM group, thanJn N-DM group. From these results regardless of cardiac function diabetic, nephr0Pathy per se is an important factor for deterioration of renal function.

Toshiki Iwate(1), Seiji Ito(t), Shuji Mukee(1), 8huichi Aoki(1,), Takashi Kategiri(1)~Mitsuham Kawemura(2)~Kazumi Chlyeda(2), Nobum Konno(2) (1)Third Department of Internal Medicine, Showa University,Tokyo 142-8666, Japan

(2)Departmentof Cardiology, Yamacashi Red Cross Hospital Yamanash1401-0002, Japan [,Purpose] Various ~fiemmatery cytokines are thought to play, an important role in the pathogat~tic mechanisms of diabetic complication. We investigated changes of leukemia inhibitoryfactom (UP--), a family of IL-6, in diabofic nephmpathy patientswith hemodlalysis. [Metho(~] The subjects were 60 hemndialysispatients (liD) and 20 healthy volunteersas control. The HD patients were classified into two groups (DM-HD, 20 patients:with diabetic nephropathy; NDM-HD, 40 patients with n o ~ i c nephropathy). We defined Angina. padiods, myocardial infarction and cardiac failure as cardiac events and then evaluated the ratio of cardiac events in each group. The ACE (I/D) polymoqohismwas typed with PCR, an.dthe LIFwesmeasuredbytheELISArnothed: [Flasults] The cardiac event ratio was 45.5% in DM-HD and 17.1% in NDM-HD. The blood cpncentratinn of LIF was 0.36_+0.04 pg/ml inthe control group, In DMHD; a significant difference was observed between the prer and post-

hemedielysis levels of bluadLIF..(0.374-0.,06 vs. 0,45-+0.1!). In corCaast, there were no significant differences between the 10re-and post-levels in NDM-HD (0.38±0.06 vs. 0.39±0.09). In addition,the bloodconcentration of L!F tended to behigher at post~=mtx~alysis than at Ixe-hemodlalysls in subjects with ID and DD ~ of ACE IConclusion]HD patients due to diabetic nephropathy had higher cardiac events ratios than those due to non-diabetic diseases. LIF, which has a crosstalk with angiotenshin II and other componentsof the renin-angintensinsystem, is Ill(elyto play a role in these events as a diabetic cardiovascular disorder.